These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8339237)

  • 1. Insights into breast cancer screening of younger women. Evidence from the 14-year follow-up of the Breast Cancer Detection Demonstration Project.
    Smart CR; Hartmann WH; Beahrs OH; Garfinkel L
    Cancer; 1993 Aug; 72(4 Suppl):1449-56. PubMed ID: 8339237
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival advantage differences by age. Evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project.
    Byrne C; Smart CR; Chu KC; Hartmann WH
    Cancer; 1994 Jul; 74(1 Suppl):301-10. PubMed ID: 8004601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project.
    Smart CR; Byrne C; Smith RA; Garfinkel L; Letton AH; Dodd GD; Beahrs OH
    CA Cancer J Clin; 1997; 47(3):134-49. PubMed ID: 9152171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
    Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of women ages 40-49 years with breast carcinoma according to method of detection.
    McPherson CP; Swenson KK; Jolitz G; Murray CL
    Cancer; 1997 May; 79(10):1923-32. PubMed ID: 9149019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of breast cancer screening on survival. A 5- to 10-year follow-up study.
    Rodes ND; Lopez MJ; Pearson DK; Blackwell CW; Lankford HD
    Cancer; 1986 Feb; 57(3):581-5. PubMed ID: 3942994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999.
    Vacek PM; Geller BM; Weaver DL; Foster RS
    Cancer; 2002 Apr; 94(8):2160-8. PubMed ID: 12001112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass screening for breast cancer.
    Strax P
    Rev Fr Gynecol Obstet; 1973 Jun; 68(6):457-66. PubMed ID: 17474655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method of tumor detection influences disease-free survival of women with breast carcinoma.
    Senie RT; Lesser M; Kinne DW; Rosen PP
    Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-year follow-up of minimal breast cancer from the Breast Cancer Detection Demonstration Project.
    Lopez MJ; Smart CR
    Surg Oncol Clin N Am; 1997 Apr; 6(2):393-401. PubMed ID: 9115504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.
    Miller AB; To T; Baines CJ; Wall C
    Ann Intern Med; 2002 Sep; 137(5 Part 1):305-12. PubMed ID: 12204013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project.
    Smart CR
    Cancer; 1994 Jul; 74(1 Suppl):296-300. PubMed ID: 8004600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
    Roder D; Webster F; Zorbas H; Sinclair S
    Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between method of detection of breast cancer and stage of disease, method of treatment, and survival in women aged 40 to 49 years.
    Maibenco D; Daoud Y; Phillips E; Saxe A
    Am Surg; 1999 Nov; 65(11):1061-6. PubMed ID: 10551757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the dissemination of mammography in the United States.
    Cronin KA; Yu B; Krapcho M; Miglioretti DL; Fay MP; Izmirlian G; Ballard-Barbash R; Geller BM; Feuer EJ
    Cancer Causes Control; 2005 Aug; 16(6):701-12. PubMed ID: 16049809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for breast cancer: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Sep; 137(5 Part 1):344-6. PubMed ID: 12204019
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993: equal value for patients younger and older than age 50 years.
    Cody HS
    Cancer; 1995 Nov; 76(9):1579-84. PubMed ID: 8635061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.